查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1535296

下一代定序（NGS）市场：依产品供应、应用和最终用户划分的产业展望，到2031年的全球预测

Next-Generation Sequencing (NGS) Market: Industry Outlook by Offering (Sample Preparation, Systems, Bioinformatics, Sequencing Services) Application (Clinical, Research) End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 451 Pages | 订单完成后即时交付

价格

预计到2031年，全球次世代定序（NGS）市场将达到 427亿美元，2024年至2031年的年复合成长率为 15.7%。

经过广泛的二次和初步研究以及对市场情景的详细分析，本报告由关键行业驱动因素、限制因素、挑战和机会分析构成。

NGS 市场的成长是由于癌症发生率上升、NGS 在癌症治疗和研究中的应用不断增加、NGS 服务提供者与製药公司之间的联盟、NGS 技术进步、最佳化和简化NGS 对工作流程的需求不断增加、基因组定序的成本下降、定序程序的技术进步、NGS 资讯学解决方案的技术进步、药品研发费增加、基因组作图计划的激增以及基于NGS 的诊断测试的监管和偿付方案而推动的。

此外，NGS 的应用不断增加，生物资讯学和基因组资料管理解决方案的采用不断增加，供应商之间在开发样本库製备方案方面的合作，以及用于大规模资料分析和解释的生物资讯学和基因组资料管理解决方案的使用不断增加，医院和临床实验室更加采用 NGS 资讯学工具，政府支持大规模基因组定序计画的举措。预计将为 NGS 市场中的公司创造成长机会。

本报告基于对四年期间（2021-2024年）行业主要市场参与者所提供的产品组合、区域格局和关键战略发展的广泛评估，提供了竞争格局。全球次世代定序（NGS）市场的主要公司包括 Illumina, Inc.（美国）、Thermo Fisher Scientific Inc.（美国）、F. Hoffmann-La Roche Ltd.（瑞士）、Revvity, Inc.（瑞士）、Revvity, Inc.（美国）、QIAGEN N.V.（荷兰）、Agilent Technologies, Inc.（美国）、Pacific Biosciences of California, Inc.（美国）、Danaher Corporation（美国）、Oxford Nanopore Technologies Plc.（英国）、MGI Tech Co.Ltd.（中国）、Tecan Group Ltd.（瑞士）、Beijing Genomics Co.（瑞士）、Beijing Genomics Institute（BGI）（中国）、Eppendorf AG（德国）、Hamilton Company（美国）、Hudson Robotics（美国）、LGC Limited（英国）、Fabric Genomics, Inc.（美国）、DNASTAR, Inc.（美国）、Eurofins Scientific SE（卢森堡）、Novogene Co.Ltd.（中国）、Novogene Co.Ltd.（中国）、Quest Diagnostics Incorporated（美国）。

在本报告调查的产品中，商业定序/外包服务领域预计将在2024年占据最大的市场占有率，达到 38.0%。此细分市场的庞大市占率归因于 NGS 服务供应商提供的优势，例如快速结果、成本效益以及适用于各种应用的广泛服务。

在本报告调查的应用中，研究和其他应用领域预计将在2024年占据次世代定序（NGS）市场的最大占有率，达到 62.2%。该细分市场的很大一部分是由测序程序成本下降、製药和生物技术公司在药物发现方面的研究力度加大、NGS 在多种临床和研究环境中的应用不断增加、药理学靶点发现推动的，这是由于使用量不断增加资讯学解决方案，以确认治疗假设并预测针对分子标靶的抑制化合物的潜在安全性。

在本报告调查的最终用户中，製药和生物技术领域预计将在2024年占据下一代定序（NGS）市场的最大占有率，达到 43.5%。该细分市场的巨大市场占有率归因于製药和生物技术公司研发支出的增加以及慢性病盛行率的上升，这推动製药和生物技术公司采用下一代定序产品成为可能。

对全球次世代定序（NGS）市场区域状况的详细分析提供了五个关键区域（北美、欧洲、亚太地区、拉丁美洲、中东和非洲）的详细定性和定量见解，以及每个地区的一系列主要国家。估计到2024年，北美将占据次世代定序（NGS）市场的最大占有率，超过 48.7%。此外，估计到2024年，美国将占据北美下一代定序（NGS）市场的最大占有率。北美市场占有率较大的原因是政府在基因组研究方面的积极举措、基于序列的研究的应用不断成长、该地区下一代测序技术主要提供者的存在以及製药企业和生物製药公司增加的研究投资，减少了定序成本加上先进定序产品和解决方案的可用性不断增加，以及癌症发生率的增加，这是由于该地区的赎回情况良好。

调查范围：

次世代定序（NGS）市场评估：依产品分类

  • 样品製备
    • 试剂盒和试剂
  • 核酸萃取与扩增
  • 样品库准备
  • DNA样品库製备
  • RNA样品库製备
  • 品质控制
  • 其他试剂（1）
    • 用于样品库製备的工作站/机器人平台
  • 序列
    • NGS系统
  • 依成分排列的顺序
  • 离子半导体序列
  • 单分子即时定序（SMRT）
  • DNA 奈米球（DNB）序列
  • 其他技术（2）
    • 服务（3）
  • 资料分析/生物资讯学
    • 软体
  • 依类型
  • 资料分析软体
  • 资料解读与报告工具
  • 资料储存/运算工具
  • 实验室资讯管理系统（LIMS）
  • 依部署类型
  • 基于网路和云端的
  • 本地
    • NGS 资讯学服务（4）
  • 商业序列/外包服务
    • 目标序列服务
    • RNA定序服务
    • 全基因组定序服务
    • 从头定序服务
    • 外显子定序服务
    • ChIP 定序服务
    • 甲基定序服务
    • 其他商业定序服务（5）

次世代定序（NGS）市场评估：依应用分类

  • 研究和其他用途
    • 药物发现
    • 农业/动物研究
    • 其他用途（6）
  • 临床应用
    • 生殖医学诊断
    • 肿瘤学
    • 传染病
    • 其他临床用途（7）

次世代定序（NGS）市场评估：依最终用户划分

  • 医院/诊断实验室
  • 製药和生技公司
  • 学术机构/研究中心
  • 其他最终用户（8）

註：1.其他试剂包括稀释缓衝液、DNA 标准品、标靶富集试剂盒/试剂、其他支持 NGS 样品製备工作流程所需的试剂。

2.其他技术包括Nanopore定序和Avidity定序技术。

3.服务包括软体升级、客户支援、设备训练、监控与安装服务等支援服务。

4.NGS资讯学服务包括生物资讯学资料分析服务、生物资讯学咨询服务、生物资讯学培训、IT专业服务等支援服务。

5.其他商业定序服务包括降解圆顶定序、核醣体分析、扩增子定序、CRISPR 验证、病毒基因组定序和免疫基因体学服务。

6.其他应用包括食品微生物学、食品和饮料行业的微生物组分析以及环境研究。

7.其他临床应用包括检测神经系统疾病、罕见疾病、代谢和免疫疾病以及食源性疾病的遗传异常。

8.其他最终用户包括法医实验室、安全机构、食品和饮料公司、农业公司。

次世代定序（NGS）市场评估：依最终用户划分

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 西班牙
    • 其他欧洲（RoE）
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他亚太地区（RoAPAC）
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 中东、非洲

目录

第1章 简介

第2章 研究方法

第3章 执行摘要

第4章 市场洞察

  • 市场
  • 摘要
  • 影响市场成长的因素
    • 市场动态影响分析
      • 癌症发生率上升以及 NGS 在癌症治疗和研究中的应用不断增加推动市场成长
      • 替代技术的可用性限制了市场成长
      • NGS 在个人化医疗中的应用扩展为市场公司创造了成长机会
      • 对资料储存、处理、解释和保密性的担忧可能仍然是市场利益相关者面临的关键问题
    • 因素分析
  • 产业趋势
    • 透过加强 NGS 解决方案提供者之间的合作伙伴关係和协作，扩大和推进产品供应
    • 携带式定序技术的发展
    • 对 NGS 自动化的需求不断增加
  • 价格分析
    • NGS 设备和耗材
    • NGS 服务
  • 监理分析
    • NGS 设备和耗材
      • 北美
        • 美国
        • 加拿大
      • 欧洲
      • 亚太地区
        • 中国
        • 日本
        • 印度
      • 拉丁美洲
      • 中东
    • NGS资讯学
  • 案例研究/使用范例
    • 案例研究 A
    • 案例研究 B
    • 个案研究 C
    • 案例研究 D
  • 波特五力分析

第5章 次世代定序（NGS）市场评估：依产品分类

  • 摘要
  • 样品製备
    • 试剂盒和试剂
      • 核酸萃取与扩增
      • 样品库准备
        • DNA样品库製备
        • RNA样品库製备
      • 品质控制
      • 其他试剂盒和试剂
    • NGS工作站
  • 序列
    • NGS系统
      • 依成分排列的顺序
      • 离子半导体序列
      • 单分子即时定序（SMRT）
      • DNA 奈米球（DNB）序列
      • 其他技术
    • 消耗品
    • 服务
  • 资料分析/生物资讯学
    • 软体
      • 软体市场，依类型
        • 资料分析软体
        • 资料解读与报告工具
        • 资料储存与运算工具
        • 实验室资讯管理系统（LIMS）
      • 软体市场：依部署模式
        • 基于网路和云端的
        • 本地
    • NGS资讯学服务
  • 商业序列/外包服务
    • 目标序列服务
    • RNA定序服务
    • 从头定序服务
    • 外显子定序服务
    • 晶片序列服务
    • 甲基定序服务
    • 全基因组定序服务
    • 其他商业定序服务

第6章 次世代定序（NGS）市场评估：依应用分类

  • 摘要
  • 研究和其他用途
    • 药物发现
    • 农业与动物研究
    • 其他用途
  • 临床应用
    • 肿瘤学
    • 生殖医学
    • 传染病
    • 其他临床应用

第7章 次世代定序（NGS）市场评估：依最终使用者

  • 摘要
  • 製药和生技公司
  • 医院和诊断实验室
  • 学术机构与研究中心
  • 其他最终用户

第8章 次世代定序（NGS）市场评估：依地区

  • 摘要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他欧洲（RoE）
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区（RoAPAC）
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲（RoLATAM）
  • 中东、非洲

第9章 竞争分析

  • 摘要
  • 主要成长策略
  • 竞争基准测试
  • 竞争对手仪表板
    • 行业领导者
    • 市场差异化因素
    • 领先企业
    • 新兴公司
  • 市占率分析（2023年）
    • 仪器和消耗品
    • 资料分析/生物资讯学
    • 商业定序/外包服务
    • NGS 工作站

第10章 公司简介（公司概况、财务概况、产品组合、策略发展）

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Eurofins Scientific Se
  • Beijing Genomics Institute（BGI）
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Revvity, Inc.
  • Pacific Biosciences of California Inc.
  • Danaher Corporation
  • Oxford Nanopore Technologies Plc.
  • Tecan Group Ltd.
  • Hamilton Company
  • Hudson Robotics
  • LGC Limited
  • Eppendorf AG
  • Novogene Co., Ltd.
  • Dnastar, Inc.
  • Fabric Genomics, Inc.
  • MGI Tech Co., Ltd.
  • Quest Diagnostics Incorporated

（*註：为前 5 名公司提供 SWOT 分析*）

第11章 附录

Product Code: MRHC - 1041274

Next-Generation Sequencing (NGS) Market: Industry Outlook by Offering (Sample Preparation [DNA Extraction, Library Preparation, Automation], Systems, Bioinformatics, Sequencing Services) Application (Clinical, Research) End User-Global Forecast to 2031

The global next-generation sequencing (NGS) market is projected to reach $42.7 billion by 2031 at a CAGR of 15.7% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities.

The growth of the NGS market is driven by the rising cancer prevalence & the increasing application of NGS in cancer treatment and research, partnerships between NGS service providers & pharmaceutical companies, technological advancements in NGS, the growing demand for optimized & streamlined NGS workflows, the declining costs of genome sequencing, technological advancements in sequencing procedures, technological advancements in NGS informatics solutions, increasing pharmaceutical R&D expenditures, the surge in genome mapping programs, and improvements in regulatory & reimbursement scenarios for NGS-based diagnostic tests.

Furthermore, the increasing applications of NGS, the rising adoption of bioinformatics and genomic data management solutions, collaborations between vendors to develop library preparation protocols, the growing use of bioinformatics and genomic data management solutions for large-scale data analysis and interpretation, the increasing adoption of NGS informatics tools among hospitals and clinical laboratories, and government initiatives supporting large-scale genomic sequencing projects are expected to generate growth opportunities for the players operating in the NGS market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global next-generation sequencing (NGS) market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), MGI Tech Co., Ltd. (China), Tecan Group Ltd. (Switzerland), Beijing Genomics Institute (BGI) (China), Eppendorf AG (Germany), Hamilton Company (U.S.), Hudson Robotics (U.S.), LGC Limited (U.K.), Fabric Genomics, Inc. (U.S.), DNASTAR, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), Novogene Co. Ltd. (China), and Quest Diagnostics Incorporated (U.S.).

Among the offerings studied in this report, in 2024, the commercial sequencing/outsourced services segment is expected to account for the largest share of 38.0% of the market. The large market share of this segment can be attributed to the benefits offered by NGS service providers, including quick results, cost-effectiveness, and a wide array of services available for various applications.

Among the applications studied in this report, in 2024, the research & other applications segment is expected to account for the largest share of 62.2% of the next-generation sequencing (NGS) market. The large share of the segment is attributed to the decreasing cost of sequencing procedures, increasing R&D by pharmaceutical and biotechnology companies for drug discovery, the increasing applications of NGS in multiple clinical and research settings, and the increasing use of informatics solutions to find pharmacological targets, confirm therapeutic hypotheses, and predict the potential safety of inhibitory compounds aimed at molecular targets.

Among the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of 43.5% of the next-generation sequencing (NGS) market. The large market share of this segment can be attributed to the increasing R&D spending by pharmaceutical & biotechnology companies and the rising incidence of chronic diseases, which drive the adoption of next-generation sequencing products among pharmaceutical & biotechnology companies.

An in-depth analysis of the geographical scenario of the global next-generation sequencing (NGS) market provides detailed qualitative and quantitative insights into five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 48.7% of the next-generation sequencing (NGS) market. Additionally, in 2024, the U.S. is expected to account for the largest share of the next-generation sequencing (NGS) market in North America. North America's large market share is attributed to the favorable government initiatives for genomic research, growing applications of sequencing-based research, presence of leading providers of next-generation sequencing technologies in the region, increasing research investments by pharmaceutical and biopharmaceutical companies, declining cost of sequencing coupled with the rising availability of advanced sequencing products and solutions, increasing cancer prevalence, and favorable reimbursement scenario in the region.

Scope of the Report:

Next-Generation Sequencing (NGS) Market Assessment-by Offering

  • Sample Preparation
    • Kits & Reagents
  • Nucleic Acid Extraction and Amplification
  • Library Preparation
  • DNA Library Preparation
  • RNA Library Preparation
  • Quality Control
  • Other Reagents (1)
    • Workstations/Robotic Platforms for Library Preparation
  • Sequencing
    • NGS Systems
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing (SMRT)
  • DNA Nanoball (DNB) Sequencing
  • Other Technologies (2)
    • Services (3)
  • Data Analysis/Bioinformatics
    • Software
  • By Type
  • Data Analysis Software
  • Data Interpretation and Reporting Tools
  • Data Storage and Computing Tools
  • Laboratory Information Management Systems (LIMS)
  • By Deployment Mode
  • Web and Cloud-based
  • On-premise
    • NGS Informatics Services (4)
  • Commercial Sequencing/ Outsourced Services
    • Targeted Sequencing Services
    • RNA Sequencing Services
    • Whole Genome Sequencing Services
    • De Novo Sequencing Services
    • Exome Sequencing Services
    • ChIP Sequencing Services
    • Methyl Sequencing Services
    • Other Commercial Sequencing Services (5)

Next-Generation Sequencing (NGS) Market Assessment-by Application

  • Research & Other Applications
    • Drug Discovery
    • Agriculture & Animal Research
    • Other Applications (6)
  • Clinical Applications
    • Reproductive Health Diagnosis
    • Oncology
    • Infectious Diseases
    • Other Clinical Applications (7)

Next-Generation Sequencing (NGS) Market Assessment-by End User

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes & Research Centers
  • Other End Users (8)

Note: 1. Other Reagents include dilution buffers, DNA standards, target enrichment kits/reagents, and other reagents required to support the NGS sample preparation workflow

2. Other Technologies include Nanopore sequencing & Avidity Sequencing Technology

3. Services include support services, such as the upgradation of software, customer support, equipment training, monitoring, installation services, and more

4. NGS informatics services include support services, such as bioinformatics data analysis services, bioinformatics consulting services, bioinformatics training, and IT professional services.

5. Other Commercial Sequencing Services include degradome sequencing, ribosome profiling, amplicon sequencing, CRISPR validation, viral genome sequencing, and immunogenomics services

6. Other Applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies

7. Other Clinical Applications include detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses

8. Other End Users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.

Next-Generation Sequencing (NGS) Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
      • 4.2.1.1. Rising Cancer Prevalence & Increasing Application of NGS in Cancer Treatment and Research Driving Market Growth
      • 4.2.1.2. Availability of Alternative Technologies Restraining Market Growth
      • 4.2.1.3. Increasing Application of NGS in Personalized Medicine Generating Growth Opportunities for Market Players
      • 4.2.1.4. Data Storage, Handling, Interpretation, and Confidentiality Concerns Expected to Remain a Major Challenge for Market Stakeholders
    • 4.2.2. Factor Analysis
  • 4.3. Industry Trends
    • 4.3.1. Increasing Partnerships & Collaborations Among NGS Solution Providers to Expand and Advance Product Offerings
    • 4.3.2. Development of Portable Sequencing Technologies
    • 4.3.3. Increasing Demand for NGS Automation
  • 4.4. Pricing Analysis
    • 4.4.1. NGS Instruments and Consumables
    • 4.4.2. NGS Services
  • 4.5. Regulatory Analysis
    • 4.5.1. NGS Instruments & Consumables
      • 4.5.1.1. North America
        • 4.5.1.1.1. U.S.
        • 4.5.1.1.2. Canada
      • 4.5.1.2. Europe
      • 4.5.1.3. Asia-Pacific
        • 4.5.1.3.1. China
        • 4.5.1.3.2. Japan
        • 4.5.1.3.3. India
      • 4.5.1.4. Latin America
      • 4.5.1.5. Middle East
    • 4.5.2. NGS Informatics
  • 4.6. Case Studies/Use Cases
    • 4.6.1. Case Study A
    • 4.6.2. Case Study B
    • 4.6.3. Case Study C
    • 4.6.4. Case Study D
  • 4.7. Porter's Five Forces Analysis
    • 4.7.1. Bargaining Power of Buyers
    • 4.7.2. Bargaining Power of Suppliers
    • 4.7.3. Threat of Substitutes
    • 4.7.4. Threat of New Entrants
    • 4.7.5. Degree of Competition

5. Next-Generation Sequencing (NGS) Market Assessment - by Offering

  • 5.1. Overview
  • 5.2. Sample Preparation
    • 5.2.1. Kits & Reagents
      • 5.2.1.1. Nucleic Acid Extraction and Amplification
      • 5.2.1.2. Library Preparation
        • 5.2.1.2.1. DNA Library Preparation
        • 5.2.1.2.2. RNA Library Preparation
      • 5.2.1.3. Quality Control
      • 5.2.1.4. Other Kits & Reagents
    • 5.2.2. NGS Workstations
  • 5.3. Sequencing
    • 5.3.1. NGS Systems
      • 5.3.1.1. Sequencing by Synthesis
      • 5.3.1.2. Ion Semiconductor Sequencing
      • 5.3.1.3. Single-Molecule Real-Time Sequencing (SMRT)
      • 5.3.1.4. DNA Nanoball (DNB) Sequencing
      • 5.3.1.5. Other Technologies
    • 5.3.2. Consumables
    • 5.3.3. Services
  • 5.4. Data Analysis/Bioinformatics
    • 5.4.1. Software
      • 5.4.1.1. Software Market, by Type
        • 5.4.1.1.1. Data Analysis Software
        • 5.4.1.1.2. Data Interpretation and Reporting Tools
        • 5.4.1.1.3. Data Storage and Computing Tools
        • 5.4.1.1.4. Laboratory Information Management Systems (LIMS)
      • 5.4.1.2. Software Market, by Deployment Mode
        • 5.4.1.2.1. Web and Cloud-Based
        • 5.4.1.2.2. On-Premise
    • 5.4.2. NGS Informatics Services
  • 5.5. Commercial Sequencing/Outsourced Services
    • 5.5.1. Targeted Sequencing Services
    • 5.5.2. RNA Sequencing Services
    • 5.5.3. De Novo Sequencing Services
    • 5.5.4. Exome Sequencing Services
    • 5.5.5. Chip Sequencing Services
    • 5.5.6. Methyl Sequencing Services
    • 5.5.7. Whole Genome Sequencing Services
    • 5.5.8. Other Commercial Sequencing Services

6. Next-Generation Sequencing (NGS) Market Assessment - by Application

  • 6.1. Overview
  • 6.2. Research & Other Applications
    • 6.2.1. Drug Discovery
    • 6.2.2. Agriculture & Animal Research
    • 6.2.3. Other Applications
  • 6.3. Clinical Applications
    • 6.3.1. Oncology
    • 6.3.2. Reproductive Health
    • 6.3.3. Infectious Diseases
    • 6.3.4. Other Clinical Applications

7. Next-Generation Sequencing (NGS) Market Assessment - by End User

  • 7.1. Overview
  • 7.2. Pharmaceutical & Biotechnology Companies
  • 7.3. Hospitals & Diagnostic Laboratories
  • 7.4. Academic Institutes & Research Centers
  • 7.5. Other End Users

8. Next-Generation Sequencing (NGS) Market Assessment - by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe (RoE)
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific (RoAPAC)
  • 8.5. Latin America
    • 8.5.1. Brazil
    • 8.5.2. Mexico
    • 8.5.3. Rest of Latin America (RoLATAM)
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Competitive Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis (2023)
    • 9.5.1. Instrument & Consumables
    • 9.5.2. Data Analysis/Bioinformatics
    • 9.5.3. Commercial Sequencing/Outsourced Services
    • 9.5.4. NGS Workstations

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 10.1. Illumina, Inc.
  • 10.2. Thermo Fisher Scientific Inc.
  • 10.3. F. Hoffmann-La Roche Ltd
  • 10.4. Eurofins Scientific Se
  • 10.5. Beijing Genomics Institute (BGI)
  • 10.6. Qiagen N.V.
  • 10.7. Agilent Technologies, Inc.
  • 10.8. Revvity, Inc.
  • 10.9. Pacific Biosciences of California Inc.
  • 10.10. Danaher Corporation
  • 10.11. Oxford Nanopore Technologies Plc.
  • 10.12. Tecan Group Ltd.
  • 10.13. Hamilton Company
  • 10.14. Hudson Robotics
  • 10.15. LGC Limited
  • 10.16. Eppendorf AG
  • 10.17. Novogene Co., Ltd.
  • 10.18. Dnastar, Inc.
  • 10.19. Fabric Genomics, Inc.
  • 10.20. MGI Tech Co., Ltd.
  • 10.21. Quest Diagnostics Incorporated

(*Note: SWOT Analysis Provided for Top 5 Companies*)

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports

LIST OF TABLES

  • Table 1 Global NGS Market: Impact Analysis of Market Dynamics (2024-2031)
  • Table 2 Global Estimated Number of New Cancer Cases, by Type (2020 Vs. 2030)
  • Table 3 Incidence of Common Genetic Disorders
  • Table 4 Major Genome Sequencing Projects, by Country
  • Table 5 Portable Sequencers Vs. Benchtop Sequencers
  • Table 6 NGS Instruments Price List
  • Table 7 NGS Consumables Price List
  • Table 8 Key NGS Service Providers' Price List
  • Table 9 Regulatory Authorities Governing In Vitro Diagnostics & NGS Products, by Country/Region
  • Table 10 NGS Software: Standards and Compliance Guidelines
  • Table 11 NGS Informatics: Standards and Compliance Guidelines
  • Table 12 Global NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 14 Global NGS Sample Preparation Market, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global NGS Sample Preparation Kits & Reagents Market, by Type, 2022-2031 USD Million)
  • Table 16 Global NGS Sample Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Nucleic Acid Extraction and Amplification Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 19 Global Library Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global DNA Library Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 21 Global RNA Library Preparation Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Quality Control Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Other Kits & Reagents Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Global NGS Workstations Market for NGS Library Preparation, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Global Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 26 Global Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global NGS Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 28 Global NGS Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 29 Global Sequencing by Synthesis Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Major Applications of Ion Torrent Sequencing
  • Table 31 Global Ion Semi Conductor Sequencing Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Smrt Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global DNA Nanoball Sequencing Systems Market, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Global Other Technologies Market, by Country/Region, 2022-2031 (USD Million)
  • Table 35 Global Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 38 Global Data Analysis/Bioinformatics Market, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Data Analysis/Bioinformatics Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global Data Analysis/Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 41 Global Data Analysis Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Global Data Interpretation and Reporting Tools Market, by Country/Region, 2022-2031 (USD Million)
  • Table 43 Global Data Storage and Computing Tools Market, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Global Laboratory Information Management Systems (LIMS) Market by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global Data Analysis/Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 46 Global Web and Cloud-Based Data/Analysis and Bioinformatics Market by Country/Region, 2022-2031 (USD Million)
  • Table 47 Global On-Premise Data/Analysis and Bioinformatics Market by Country/Region, 2022-2031 (USD Million)
  • Table 48 Global NGS Informatics Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 49 Global NGS Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 50 Global Commercial Sequencing/Outsourced Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 51 Global Targeted Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 52 Global RNA Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 53 Global De Novo Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global Exome Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 55 Global Chip Sequencing Services Market by Country/Region, 2022-2031 (USD Million)
  • Table 56 Global Methylation Sequencing Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 57 Global Whole Genome Sequencing Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 58 Global Other Commercial Sequencing Services Market, by Country/Region, 2022-2031 (USD Million)
  • Table 59 Global Next-Generation Sequencing (NGS) Market, by Application, 2022-2031 (USD Million)
  • Table 60 Global NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 61 Global NGS Market for Research & Other Applications by Country/Region, 2022-2031 (USD Million)
  • Table 62 Global NGS Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
  • Table 63 Global NGS Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
  • Table 64 Global NGS Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 65 Global NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 66 Global NGS Market for Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 67 Currently Available Targeted Therapies and Corresponding Biomarkers
  • Table 68 Global NGS Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 69 Global NGS Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
  • Table 70 Number of New HIV Infections, by Region, 2022
  • Table 71 Global NGS Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 72 Global NGS Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 73 Global Next-Generation Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 74 Pharmaceutical Spending in Major Countries
  • Table 75 Global Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, by Offering, 2022-2031 (USD Million)
  • Table 76 Global Next-Generation Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 77 Global Next-Generation Sequencing Market for Hospitals & Diagnostic Laboratories, by Offering, 2022-2031 (USD Million)
  • Table 78 Global Next-Generation Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 79 Global Next-Generation Sequencing Market for Academic Institutes & Research Centers, by Offering, 2022-2031 (USD Million)
  • Table 80 Global Next-Generation Sequencing Market for Academic Institutes & Research Centers, by Country/Region, 2022-2031 (USD Million)
  • Table 81 Global Next-Generation Sequencing Market for Other End Users, by Offering, 2022-2031 (USD Million)
  • Table 82 Global Next-Generation Sequencing Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 83 Global NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 84 North America: NGS Market, by Country, 2022-2031 (USD Million)
  • Table 85 North America: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 86 North America: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 87 North America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 88 North America: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 89 North America: Sequencing Market, by Type, 2022-2031 (USD Million)
  • Table 90 North America: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 91 North America: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 92 North America: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 93 North America: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 94 North America: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 95 North America: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 96 North America: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 97 North America: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 98 North America: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 99 U.S.: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 100 U.S.: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 101 U.S.: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 102 U.S.: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 103 U.S.: Sequencing Market, by Type, 2022-2031 (USD Million)
  • Table 104 U.S.: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 105 U.S.: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 106 U.S.: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 107 U.S.: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 108 U.S.: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 109 U.S.: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 110 U.S.: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 111 U.S.: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 112 U.S.: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 113 Canada: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 114 Canada: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 115 Canada: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 116 Canada: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 117 Canada: Sequencing Market, by Type, 2022-2031 (USD Million)
  • Table 118 Canada: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 119 Canada: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 120 Canada: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 121 Canada: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 122 Canada: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 123 Canada: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 124 Canada: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 125 Canada: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 126 Canada: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 127 Europe: NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 128 Europe: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 129 Europe: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 130 Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 131 Europe: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 132 Europe: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 133 Europe: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 134 Europe: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 135 Europe: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 136 Europe: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 137 Europe: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 138 Europe: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 139 Europe: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 140 Europe: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 141 Europe: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 142 Germany: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 143 Germany: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 144 Germany: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 145 Germany: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 146 Germany: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 147 Germany: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 148 Germany: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 149 Germany: NGS Bioinformatics Software Market, by Offering, 2022-2031 (USD Million)
  • Table 150 Germany: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 151 Germany: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 152 Germany: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 153 Germany: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 154 Germany: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 155 Germany: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 156 France: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 157 France: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 158 France: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 159 France: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 160 France: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 161 France: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 162 France: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 163 France: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 164 France: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 165 France: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 166 France: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 167 France: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 168 France: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 169 France: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 170 U.K.: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 171 U.K.: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 172 U.K.: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 173 U.K.: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 174 U.K.: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 175 U.K.: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 176 U.K.: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 177 U.K.: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 178 U.K.: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 179 U.K.: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 180 U.K.: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 181 U.K.: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 182 U.K.: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 183 U.K.: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 184 Italy: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 185 Italy: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 186 Italy: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 187 Italy: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 188 Italy: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 189 Italy: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 190 Italy: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 191 Italy: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 192 Italy: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 193 Italy: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 194 Italy: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 195 Italy: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 196 Italy: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 197 Italy: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 198 Spain: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 199 Spain: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 200 Spain: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 201 Spain: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 202 Spain: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 203 Spain: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 204 Spain: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 205 Spain: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 206 Spain: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 207 Spain: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 208 Spain: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 209 Spain: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 210 Spain: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 211 Spain: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 212 Roe: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 213 Rest of Europe: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 214 Rest of Europe: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 215 Rest of Europe: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 216 Rest of Europe: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 217 Rest of Europe: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 218 Rest of Europe: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 219 Rest of Europe: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 220 Rest of Europe: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 221 Rest of Europe: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 222 Rest of Europe: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 223 Rest of Europe: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 224 Rest of Europe: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 225 Rest of Europe: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 226 Rest of Europe: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 227 Asia-Pacific: NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 228 Asia-Pacific: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 229 Asia-Pacific: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 230 Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 231 Asia-Pacific: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 232 Asia-Pacific: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 233 Asia-Pacific: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 234 Asia-Pacific: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 235 Asia-Pacific: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 236 Asia-Pacific: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 237 Asia-Pacific: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 238 Asia-Pacific: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 239 Asia-Pacific: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 240 Asia-Pacific: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 241 Asia-Pacific: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 242 China: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 243 China: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 244 China: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 245 China: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 246 China: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 247 China: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 248 China: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 249 China: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 250 China: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 251 China: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 252 China: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 253 China: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 254 China: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 255 China: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 256 Japan: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 257 Japan: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 258 Japan: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 259 Japan: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 260 Japan: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 261 Japan: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 262 Japan: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 263 Japan: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 264 Japan: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 265 Japan: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 266 Japan: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 267 Japan: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 268 Japan: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 269 Japan: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 270 India: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 271 India: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 272 India: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 273 India: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 274 India: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 275 India: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 276 India: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 277 India: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 278 India: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 279 India: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 280 India: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 281 India: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 282 India: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 283 India: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 284 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 285 Rest of Asia-Pacific: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 286 Rest of Asia-Pacific: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 287 Rest of Asia-Pacific: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 288 Rest of Asia-Pacific: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 289 Rest of Asia-Pacific: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 290 Rest of Asia-Pacific: Sequencing Systems Market, by Technology, 2022-2031 (USD Million)
  • Table 291 Rest of Asia-Pacific: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 292 Rest of Asia-Pacific: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 293 Rest of Asia-Pacific: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 294 Rest of Asia-Pacific: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 295 Rest of Asia-Pacific: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 296 Rest of Asia-Pacific: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 297 Rest of Asia-Pacific: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 298 Rest of Asia-Pacific: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 299 Latin America: NGS Market, by Country/Region, 2022-2031 (USD Million)
  • Table 300 Latin America: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 301 Latin America: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 302 Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 303 Latin America: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 304 Latin America: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 305 Latin America: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 306 Latin America: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 307 Latin America: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 308 Latin America: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 309 Latin America: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 310 Latin America: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 311 Latin America: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 312 Latin America: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 313 Latin America: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 314 Brazil: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 315 Brazil: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 316 Brazil: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 317 Brazil: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 318 Brazil: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 319 Brazil: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 320 Brazil: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 321 Brazil: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 322 Brazil: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 323 Brazil: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 324 Brazil: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 325 Brazil: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 326 Brazil: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 327 Brazil: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 328 Mexico: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 329 Mexico: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 330 Mexico: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 331 Mexico: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 332 Mexico: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 333 Mexico: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 334 Mexico: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 335 Mexico: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 336 Mexico: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 337 Mexico: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 338 Mexico: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 339 Mexico: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 340 Mexico: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 341 Mexico: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 342 Rest of Latin America: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 343 Rest of Latin America: Sample Preparation Market, by Type, 2022-2031 (USD Million)
  • Table 344 Rest of Latin America: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 345 Rest of Latin America: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 346 Rest of Latin America: Sequencing Market, by Type, 2022-2031 (USD Million)
  • Table 347 Rest of Latin America: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 348 Rest of Latin America: Data Analysis/Bioinformatics Market, by Type, 2022-2031 (USD Million)
  • Table 349 Rest of Latin America: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 350 Rest of Latin America: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 351 Rest of Latin America: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 352 Rest of Latin America: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 353 Rest of Latin America: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 354 Rest of Latin America: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 355 Rest of Latin America: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 356 Middle East & Africa: NGS Market, by Offering, 2022-2031 (USD Million)
  • Table 357 Middle East & Africa: Sample Preparation Market, by Offering, 2022-2031 (USD Million)
  • Table 358 Middle East & Africa: Sample Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 359 Middle East & Africa: Library Preparation Kits & Reagents Market, by Type, 2022-2031 (USD Million)
  • Table 360 Middle East & Africa: Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 361 Middle East & Africa: NGS Market, by Technology, 2022-2031 (USD Million)
  • Table 362 Middle East & Africa: Data Analysis/Bioinformatics Market, by Offering, 2022-2031 (USD Million)
  • Table 363 Middle East & Africa: NGS Bioinformatics Software Market, by Type, 2022-2031 (USD Million)
  • Table 364 Middle East & Africa: NGS Bioinformatics Software Market, by Deployment Mode, 2022-2031 (USD Million)
  • Table 365 Middle East & Africa: Commercial Sequencing/Outsourced Services Market, by Type, 2022-2031 (USD Million)
  • Table 366 Middle East & Africa: NGS Market, by Application, 2022-2031 (USD Million)
  • Table 367 Middle East & Africa: NGS Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 368 Middle East & Africa: NGS Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 369 Middle East & Africa: NGS Market, by End User, 2022-2031 (USD Million)
  • Table 370 Recent Developments, by Company, 2021-2024
  • Table 371 Illumina IVD Instrument Specification
  • Table 372 Illumina Informatics Options for Dx Instruments
  • Table 373 Supported IVD Assays
  • Table 374 Supported Clinical Research Panels in Ruo Mode
  • Table 375 IVD Instrument Comparison Table
  • Table 376 Key Specifications (Dx Mode)
  • Table 377 Production-Scale Sequencers Specifications
  • Table 378 Production-Scale Sequencers - Key Applications and Methods
  • Table 379 Illumina, Inc. (U.S.): NGS Systems Installed Base & New Installations In 2022
  • Table 380 Illumina, Inc. (U.S.): NGS Systems Installed Base & New Installations In 2023

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for This Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Next-Generation Sequencing Market, By Offering, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global Next-Generation Sequencing Market, By Application, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Next-Generation Sequencing Market, By End User, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global Next-Generation Sequencing Market, By Geography, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global Pharmaceutical R&D Expenditure, 2012-2026 (USD Billion)
  • Figure 12 U.S.: Percentage of Personalized Medicine Approvals Among Total FDA Approvals, 2015-2022 (%)
  • Figure 13 Genome Sequencing Costs, 2016-2022 (USD)
  • Figure 14 USFDA Regulatory Pathways for IVD Kits
  • Figure 15 Eu Regulatory Pathway - IVDR 2017/746
  • Figure 16 China: Medical Device Classification and Pre-Market Requirements for NGS Instruments
  • Figure 17 Porter's Five Forces Analysis
  • Figure 18 Global NGS Market, By Offering, 2024 Vs 2031 (USD Million)
  • Figure 19 Steps of Sample Preparation in A Typical NGS Workflow
  • Figure 20 Global: Estimated Number of New Cancer Cases, 2022 - 2030
  • Figure 21 Global Next-Generation Sequencing (NGS) Market, By Application, 2024 Vs. 2031 (USD Million)
  • Figure 22 U.S.: New Molecular Entity (NME) Approvals, 2011-2022
  • Figure 23 Estimated Number of New Cancer Cases, 2020-2040 (In Million)
  • Figure 24 Global Next-Generation Sequencing Market, By End User, 2024 Vs. 2031 (USD Million)
  • Figure 25 Global Pharmaceutical R&D Spending, 2014-2028 (USD Billion)
  • Figure 26 NGS Market Assessment, By Region, 2024 Vs. 2031 (USD Million)
  • Figure 27 North America: Per Capita Healthcare Expenditure, 2017-2022
  • Figure 28 North America: NGS Market Snapshot
  • Figure 29 Europe: Pharmaceutical R&D Expenditure Annual Growth Rate (%)
  • Figure 30 Europe: NGS Market Snapshot
  • Figure 31 Italy: Number of Biotechnology and Biotechnology R&D-Dedicated Firms, 2014-2022
  • Figure 32 Spain Pharmaceutical R&D Expenditure, 2018-2022 (USD Million)
  • Figure 33 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
  • Figure 34 Asia-Pacific: NGS Market Snapshot
  • Figure 35 Japan: Pharmaceutical Industry R&D Expenditure, 2017-2022 (USD Million)
  • Figure 36 Japan: Number of New Molecular Entities Approved, 2017-2022
  • Figure 37 Latin America: NGS Market Snapshot
  • Figure 38 Number of Active Life Science Companies in Israel (2017-2022)
  • Figure 39 Key Growth Strategies Adopted by Leading Players, 2021- 2024
  • Figure 40 Next-Generation Sequencing Market: Competitive Benchmarking by Offering
  • Figure 41 Next-Generation Sequencing Market: Competitive Benchmarking, by Region
  • Figure 42 Competitive Dashboard: Next-Generation Sequencing Market
  • Figure 43 Illumina, Inc.: Financial Snapshot (2023)
  • Figure 44 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
  • Figure 45 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
  • Figure 46 Eurofins Scientific Se: Financial Overview (2023)
  • Figure 47 Beijing Genomics Institute (BGI): Financial Snapshot (2023)
  • Figure 48 Qiagen N.V: Financial Snapshot (2023)
  • Figure 49 Agilent Technologies, Inc.: Financial Snapshot (2023)
  • Figure 50 Revvity, Inc.: Financial Snapshot (2023)
  • Figure 51 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
  • Figure 52 Danaher Corporation: Financial Snapshot (2023)
  • Figure 53 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)
  • Figure 54 Tecan Group Ltd.: Financial Snapshot (2023)
  • Figure 55 LGC Limited: Financial Overview (2023)
  • Figure 56 Eppendorf Ag: Financial Overview (2023)
  • Figure 57 Novogene Co., Ltd.: Financial Overview (2023)
  • Figure 58 MGI Tech Co., Ltd.: Financial Snapshot (2023)
  • Figure 59 Quest Diagnostics Incorporated: Financial Overview (2023)